INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 425m ago
HOUSE PTR24m ago
SEC 13F24m ago
ROBINHOOD CHAIN24m ago
Public company

RANIRani Therapeutics Holdings, Inc.

CIK 0001856725

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 0
Max Insider Score9
Connections7with evidence

RANI · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
JA
Javadi AlirezaChief Technical Officer
RANIRani Therapeutics Holdings, Inc.
Grant or award
A—
805.5K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    McKinley KateChief Business Officer · Jun 5, 2026
  • ← Insider ofevidence
    Imran TalatDirector, Chief Executive Officer · Jun 5, 2026
  • ← Insider ofevidence
    Javadi AlirezaChief Technical Officer · Jun 5, 2026
9
MK
McKinley KateChief Business Officer
RANIRani Therapeutics Holdings, Inc.
Grant or award
A
—
805.5K sh
Jun 3, 2026
Jun 5, 2026
traded Jun 3, 2026
+2d
SEC FORM 4

Evidence

9
IT
Imran TalatDirector, Chief Executive Officer
RANIRani Therapeutics Holdings, Inc.
Grant or award
A—
3.80M sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC FORM 4

Evidence

9
BJ
Bailey Vasudev JaiprakashDirector
RANIRani Therapeutics Holdings, Inc.
Grant or award
A—
123.6K sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

9
RA
Rometty Lisa AnnDirector
RANIRani Therapeutics Holdings, Inc.
Grant or award
A—
123.6K sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

9
BA
Bassan AbrahamDirector
RANIRani Therapeutics Holdings, Inc.
Grant or award
A—
123.6K sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Bailey Vasudev JaiprakashDirector · Jun 1, 2026
  • ← Insider ofevidence
    Rometty Lisa AnnDirector · Jun 1, 2026
  • ← Insider ofevidence
    Bassan AbrahamDirector · Jun 1, 2026